Edit Symbol List
SRLS: Stock Quote & Summary Data
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 20,064 |
| Previous Close | $ 2.95 |
| 52 Wk High / Low | $ 3.11 / $ 0.27 |
| Shares Outstanding | 18,653,000 |
| Market Value | $ 67,710,390 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | -0.17 |
| NASDAQ Official Open Price: | $ 3.15 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 3.50 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About SRLS?
Ask your question about about SeraCare Life Sciences Inc (SRLS) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company’s innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare’s quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry. The Company’s business is divided into two segments: Diagnostic & Biopharmaceutical Products and BioServices. ... More ...
Links to all SeraCare Life Sciences Inc (SRLS) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for SRLS |
||
|
SeraCare Life Sciences Swings To Profit In Q4 - Quick Facts - RTT News 11/19/2009 4:55PM |
||
|
SeraCare Reports Fourth Quarter and Fiscal Year 2009 Results - Business Wire 11/19/2009 4:03PM |
||
|
SeraCare Life Sciences Awarded Multiple Contracts from the CDC and NIH to Support HIV Research and the Accuracy of HIV Testing - Business Wire 09/29/2009 4:03PM |
||
|
SeraCare Life Sciences Swings To Profit In Q3 - Quick Facts - RTT News 08/11/2009 5:00PM |
||
|
SeraCare Reports Third Quarter Fiscal Year 2009 Results - Business Wire 08/11/2009 4:03PM |
||
|
SeraCare Life Sciences To Present At Canaccord Adams 29th Annual Global Growth Conference At 5:00 PM - RTT News 08/11/2009 2:57PM |
||
|
SeraCare Life Sciences to Present at Canaccord Adams 29th Annual Global Growth Conference - Business Wire 08/10/2009 8:03AM |



Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
23.05%

